Prostate Cancer Clinical Trial

The PROVENT study is a clinical trial for men diagnosed with prostate cancer who are on active surveillance. It aims to test whether Aspirin and/or Vitamin D3 have the potential to stop low and intermediate risk prostate cancers from developing into high risk cancers.

Homerton University Hospital. University College London Hospital, St Bartholomew’s Hospital and University Hospital Coventry are all currently recruiting participants to the study. If your prostate cancer is being managed via active surveillance in any of the aforementioned hospitals and you are interested in joining the study, please contact a member of the team in charge of your care.

Study participation will also be available to active surveillance patients at the following hospitals in the near future; Guy’s Hospital London, Southampton General Hospital, Oxford University Hospital, Darent Valley Hospital, Western General Hospital and University Hospital of Wales.

More information can be found at the study website    

Back to News